Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.
about
Depression as a Glial-Based Synaptic DysfunctionTranscriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophreniaSialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationLentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognitionAltered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressantsRETRACTED: Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain.Increasing maternal or post-weaning folic acid alters gene expression and moderately changes behavior in the offspringRole of the axonal initial segment in psychiatric disorders: function, dysfunction, and interventionLower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophreniaLate pregnancy thyroid-binding globulin predicts perinatal depressionThe neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus.Vinorelbine and epirubicin share common features with polysialic acid and modulate neuronal and glial functionsBrain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM.ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.Neuropathology of mood disorders: do we see the stigmata of inflammation?Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophreniaStructural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders.Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia.Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex.Biological roles of glycans.Effects of Chronic Dopamine D2R Agonist Treatment and Polysialic Acid Depletion on Dendritic Spine Density and Excitatory Neurotransmission in the mPFC of Adult Rats.Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls.A cell culture model for investigation of synapse influenceability: epigenetics, expression and function of gene targets important for synapse formation and preservation in SH-SY5Y neuroblastoma cells differentiated by retinoic acid.Orientin improves depression-like behavior and BDNF in chronic stressed mice.Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.Different properties of polysialic acids synthesized by the polysialyltransferases ST8SIA2 and ST8SIA4.Electrical Stimulation with a Conductive Polymer Promotes Neurite Outgrowth and Synaptogenesis in Primary Cortical Neurons in 3D.
P2860
Q26772830-61C4F000-7DC0-4B10-9831-D21300AFD7CEQ26991794-3AC60A56-21E8-4D0C-80F8-FC5A5855F56EQ26995291-08A0EA85-A7B6-47C2-A1DE-CA80C619C030Q30422055-7F93B31C-49BB-4360-B182-E19EB3E9EA7BQ30887852-E6B2F18A-6ED6-40AA-AF98-4EA8837FC07EQ33853853-29DAAA2A-782B-43D0-9F53-7372F8241F09Q33875140-A6002942-BEDC-4B7E-A771-8F1F10FFD643Q34071914-9092088E-6710-401C-B26D-811CE5123596Q34587796-7CBD81D5-8296-49B7-BDDD-34D1C458D6F1Q36578117-0452626C-3C3F-4E1E-90B2-DB430D316049Q36830911-B49D6EBD-3AC9-48D2-9730-263D16F50D48Q36996210-48E6AA61-97D6-4336-9C7C-669321243A5DQ37058646-C88885FA-9C78-44AA-82B4-26B71C22091DQ37456494-0316EB65-F3A6-4A6F-BCAC-D2CFC6113B01Q37648274-734F6871-5D5A-4FEF-8863-3AFFD2CAAADFQ37723680-688EEAEA-3482-4D9C-80FE-FF41DDBFEAB3Q38077106-FC40E681-1D9A-47BE-A771-D928E829F18CQ38106974-3A55051E-3830-4CE0-9EC7-236ADF4D269AQ38702407-2FB4AAAC-52B5-4144-961C-BDB9E999857BQ38936714-2D8C2A0B-04D9-493B-9FF5-37D19597710AQ39897250-A27244A8-E544-455D-B761-083BA362CDE6Q47553551-5BAC11C2-DFEC-4B20-A9A4-846F0857972BQ47703847-84DFEF5D-9869-4B7E-BE4C-CCB682A38DF1Q48093314-4117BA0F-A74E-42E5-AEE7-2D9A385A5589Q48463317-7DE71C36-A5C3-4EC2-A83F-E5D2BF1213E9Q51743706-D7F0ADB1-8D51-40D7-A2B2-85367DB4430CQ53110636-E99F522B-27E5-4F94-AF52-7A00B417EB25Q55516071-8D35696E-8691-44C2-AB53-B9520BF8BA90
P2860
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Alterations in the expression ...... psychiatric disorder patients.
@en
Alterations in the expression ...... psychiatric disorder patients.
@nl
type
label
Alterations in the expression ...... psychiatric disorder patients.
@en
Alterations in the expression ...... psychiatric disorder patients.
@nl
prefLabel
Alterations in the expression ...... psychiatric disorder patients.
@en
Alterations in the expression ...... psychiatric disorder patients.
@nl
P50
P1433
P1476
Alterations in the expression ...... psychiatric disorder patients.
@en
P2093
Carlos Crespo
José Miguel Blasco-Ibáñez
P304
P356
10.1016/J.NEULET.2012.09.032
P407
P577
2012-09-26T00:00:00Z